Bp PLC Abb Vie Inc. Transaction History

Bp PLC

  • $13.6 Million
  • Q2 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$106.4 - $120.78 $4.22 Million - $4.79 Million
-39,669 Closed
0 $0
Q2 2021

Aug 09, 2021
SELL
$105.21 - $117.21 $12.2 Million - $13.6 Million
-116,227 Reduced 74.55%
39,669 $4.47 Million
Q1 2021

May 13, 2021
SELL
$102.3 - $112.62 $3.48 Million - $3.83 Million
-34,036 Reduced 17.92%
155,896 $16.9 Million
Q4 2020

Feb 08, 2021
BUY
$80.49 - $108.67 $4.33 Million - $5.84 Million
53,779 Added 39.5%
189,932 $20.3 Million
Q3 2020

Oct 30, 2020
SELL
$85.91 - $100.83 $7.8 Million - $9.16 Million
-90,847 Reduced 40.02%
136,153 $11.9 Million
Q2 2020

Aug 05, 2020
BUY
$73.37 - $98.18 $2.13 Million - $2.85 Million
29,000 Added 14.65%
227,000 $22.3 Million
Q1 2020

May 05, 2020
SELL
$64.5 - $97.79 $1.16 Million - $1.76 Million
-18,000 Reduced 8.33%
198,000 $15 Million
Q4 2019

Feb 07, 2020
BUY
$72.13 - $90.25 $4.69 Million - $5.87 Million
65,000 Added 43.05%
216,000 $19.1 Million
Q2 2019

Jul 29, 2019
SELL
$65.7 - $83.98 $131,400 - $167,960
-2,000 Reduced 1.31%
151,000 $11 Million
Q1 2019

May 08, 2019
SELL
$77.14 - $90.79 $694,260 - $817,110
-9,000 Reduced 5.56%
153,000 $12.3 Million
Q4 2018

Feb 06, 2019
SELL
$77.85 - $96.01 $3.04 Million - $3.74 Million
-39,000 Reduced 19.4%
162,000 $14.9 Million
Q2 2018

Jul 30, 2018
SELL
$89.78 - $106.23 $1.44 Million - $1.7 Million
-16,000 Reduced 7.37%
201,000 $18.6 Million
Q1 2018

Apr 26, 2018
BUY
$92.01 - $123.21 $2.94 Million - $3.94 Million
32,000 Added 17.3%
217,000 $20.5 Million
Q4 2017

Feb 06, 2018
SELL
$89.56 - $98.21 $210,824 - $231,186
-2,354 Reduced 1.26%
185,000 $17.9 Million
Q3 2017

Oct 30, 2017
BUY
$69.85 - $89.22 $13.1 Million - $16.7 Million
187,354
187,354 $16.6 Million

Others Institutions Holding ABBV

# of Institutions
3,699
Shares Held
1.27B
Call Options Held
13M
Put Options Held
9.79M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bp PLC Portfolio

Follow Bp PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

News

Stay updated on Bp PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email